Full history for every metric is available with a Kvantra account
Stock profile
Juniper Pharmaceuticals, Inc. (JNP)
Current price
11.50 USD0.00%
Last close 23 Aug 2018Benchmarks
Key financial summary
Financials in USD| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 26 | 29 | 32 | 38 | 55 | 50 | 56 |
| Operating profit | $m | -3 | -2 | |||||
| Net profit | $m | 10 | 7 | 3 | -2 | 6 | -2 | -1 |
| EPS reported | $ | -0.19 | -0.10 | |||||
| Operating cashflow per share | $ | - | 0.20 | |||||
| Capex per share | $ | - | 0.26 | |||||
| FCF per share | $ | - | -0.07 | |||||
| Free cash flow | $m | -1 | -1 | |||||
| Net debt | $m | -18 | -17 | |||||
| Book value equity | $m | 42 | 48 | |||||
| Book value per share | $ | 3.84 | 4.37 | |||||
| Number of shares | m | 10.82 | 11.1 | |||||
| DPS (TTM paid) | $ | - | 0.00 |
Financial summary
Financials in USD| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.28 | 3.00 | |||||
| P/S LTM | x | 1.06 | 0.00 | |||||
| P/FCF LTM | x | -74.39 | 0.00 | |||||
| EV/EBITDA LTM | x | -42.49 | 21.18 | |||||
| EV/Sales LTM | x | - | -0.35 | |||||
| Earnings Yield LTM | % | - | -1.65% | |||||
| FCF Yield | % | -1.34% | - | |||||
| Quality | ||||||||
| ROE | % | - | -5.07% | |||||
| ROIC | % | - | -6.23% | |||||
| Operating margin | % | - | -6.17% | |||||
| Gross margin | % | - | 42.05% | |||||
| FCF/Sales | % | - | -1.43% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -8.42% | -3.60% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | - | -0.68% | |||||
| FCF/Debt | x | -0.19 | -0.42 | |||||
| Net Debt/EBITDA | x | - | 21.18 | |||||
| EBIT/Net interest | x | - | -23.74 | |||||
| Net debt/market cap | % | -33.27% | - | |||||
| Net debt/Equity | x | -0.43 | -0.36 | |||||
| Gross debt/equity | x | 0.09 | 0.07 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
JN
Juniper Pharmaceuticals, Inc. (JNP)
JNP · NASDAQ · Healthcare
11.50 USD0.00%
Benchmarks
Financialsin USD
20162017TTM
Total revenue $m555056
Operating profit $m-3-2
Net profit $m6-2-1
EPS reported $-0.19-0.10
About
No description available.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free